Stahl Neil 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2024/2/8 申報
- 申報編號
- 0001968202-24-000056
- 申報時間
- 2024/2/8
- 交易日
- 2024/2/7
- 申報延遲
- 1 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 7 筆非衍生性交易。公開市場賣出合計 $763.8 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Stahl NeilCIK 0001226689 | 高階主管（EVP Research and Development） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/2/7 | Common Stock | S賣出處分 | −100 | $947.34 | −$94,734 | 59,956 | 直接 | |
| 2024/2/7 | Common Stock | S賣出處分 | −1,894 | $948.69F1 | −$1,796,818.86 | 58,062 | 直接 | |
| 2024/2/7 | Common Stock | S賣出處分 | −601 | $949.45F2 | −$570,619.45 | 57,461 | 直接 | |
| 2024/2/7 | Common Stock | S賣出處分 | −3,127 | $950.43F3 | −$2,971,994.61 | 54,334 | 直接 | |
| 2024/2/7 | Common Stock | S賣出處分 | −1,237 | $951.49F4 | −$1,176,993.13 | 53,097 | 直接 | |
| 2024/2/7 | Common Stock | S賣出處分 | −1,059 | $952.49F5 | −$1,008,686.91 | 52,038 | 直接 | |
| 2024/2/7 | Common Stock | S賣出處分 | −19 | $953.00 | −$18,107 | 52,019 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents volume-weighted average price of sales of 1,894 shares of Company stock on February 7, 2024 at prices ranging from $948.19 to $948.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Represents volume-weighted average price of sales of 601 shares of Company stock on February 7, 2024 at prices ranging from $949.22 to $949.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 3,127 shares of Company stock on February 7, 2024 at prices ranging from $950.00 to $950.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 1,237 shares of Company stock on February 7, 2024 at prices ranging from $951.00 to $951.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 1,059 shares of Company stock on February 7, 2024 at prices ranging from $952.03 to $952.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。